Opposing efficacy of group III mGlu receptor activators, LSP1-2111 and AMN082, in animal models of positive symptoms of schizophrenia

Authors
Publication date
1 January 2011
Publisher
Springer-Verlag
Doi
    View on PubMed

    Abstract

    Abstract is not available.

      Similar works

      Full text

      thumbnail-image

      Available Versions

      Springer - Publisher Connector

      redirect
      Last time updated on 05/06/2019

      Springer - Publisher Connector

      redirect
      Last time updated on 03/05/2017

      Crossref

      redirect
      oaiinfo:doi/10.1007%2Fs00213-011-...
      Last time updated on 01/04/2019